Multi-Formula Coating for ODFs: Tackling Combination Drug Challenges
Share
As Oral Dissolvable Films (ODFs) expand their role in both pharmaceuticals and functional supplements, multi-ingredient formulations have become a key development trend. Whether it’s drug combinations or synergistic nutrition (like vitamins and minerals), ensuring stable, uniform distribution of multiple actives on a single film presents a serious technical challenge.
Industry Pain Points
Traditional single-solution coating methods face the following limitations when formulating multi-ingredient ODFs:
- Incompatible solubility leads to sedimentation or phase separation
- Uneven API distribution affects dissolution curve consistency
- Formulation ratios become unstable during scale-up
- Cross-interactions between actives hinder quality and compliance
These issues severely limit the industrialization of combination ODFs. In pharma registration, poor dissolution consistency can directly lead to rejection.
HUANGHAI’s Multi-Formula Coating Solution
HUANGHAI has developed a patented stripe-style multi-formula coating process that enables precise zone-based coating on a shared substrate:
- Independent Zones: Physically separate each formulation area to prevent cross-contamination
- Micron-Level Precision: Achieved via blade-type coating, ensuring uniform thickness
- Flexible Design: Supports dual, triple, or more component zones per film
- GMP Compatibility: Enables consistent, repeatable results for registered drug products
This technology is ideal for formulation screening during pharmaceutical R&D, as well as functional food innovation at lab and pilot scale.
Patent Backing
This coating method is protected under Chinese patent CN117323228A, viewable on Google Patents.
Recommended Equipment
- MJ150-L ODF Coating Machine – For small- and medium-scale production
- MJ150 ODF Coating Machine – For commercial-scale manufacturing
Conclusion
Combination ODFs are driven by real-world market needs, but demand robust technical execution. HUANGHAI’s multi-formula coating innovation provides a scalable, compliant solution from formulation to registration—making “multi-API, one film” a commercial reality.
*Features Huanghai's exclusive patented hot-air drying technology (Patent No. CN201668734U) ensuring uniform bottom-up heating.
Frequently Asked Questions
Q: What is the difference between an ODF film and a transdermal patch?
A: Oral Dissolving Films (ODF) are placed on or under the tongue and dissolve within seconds to minutes, delivering APIs directly through the oral mucosa or via swallowing. Transdermal patches adhere to the skin and deliver APIs through the dermal layers into systemic circulation over hours to days. Despite different delivery routes, both are manufactured using similar solvent-cast film coating processes. Huanghai's MJ150 ODF machine supports both applications on a single platform with approximately 2 working days of changeover time.
Q: What production output can I expect from a Huanghai ODF machine?
A: The MJ150 produces 20,000 films/hour at commercial scale. The MJ150-L targets R&D and pilot production at 8,000–10,000 films/hour. For fully integrated lines, pair either machine with the MJF180 automatic cutting and packaging system (11,900 films/hr) or the more affordable EZ320 (9,000 films/hr). A complete MJ150 + MJF180 line can produce over 150 million finished pouches annually on a single-shift basis. Contact us for pricing and configuration details.
Q: What drying technology does Huanghai use for ODF production?
A: Huanghai uses patented gradient hot-air drying (Patent CN201668734U), which applies a smooth progressive temperature drop rather than stepwise oven zones used by competitors. This results in more uniform film thickness, reduced edge curl, and better API distribution across the film web. An optional far-infrared heating module adds 20–30% drying efficiency for solvent-based formulations. This patented drying system is one of the key technical advantages that justifies Huanghai's position as the preferred ODF equipment supplier to Sinopharm, Shanghai Pharma, and Fosun Pharma.
Q: What are the GMP requirements for ODF production equipment?
A: ODF manufacturing equipment must comply with cGMP (21 CFR Parts 210/211) for US market products, and equivalent standards (EU GMP Annex 1, ChGMP) for other markets. Key requirements: material contact surfaces must be 316L stainless steel or equivalent; CIP/SIP capability or documented cleaning validation; data integrity controls meeting ALCOA+ principles (audit trails, access control). Huanghai ODF machines meet these standards—all product contact surfaces use pharmaceutical-grade materials, and the control system includes operator access logs and parameter change records. Request our GMP compliance documentation.
Q: Can Huanghai machines produce stripe-coated or multi-formula ODF films?
A: Yes. Huanghai holds a patent for multi-formula stripe coating (Patent CN117323228A), enabling two different API formulations to be applied side-by-side in a single coating pass. This eliminates the need for multiple coating/drying cycles when producing combination-drug ODF products. Competitors require manual multi-layer coating with drying intervals between each formula. This capability is particularly valuable for fixed-dose combination products (e.g., dual-API ODFs for cardiovascular or CNS indications) where coating efficiency directly impacts production economics.
Verify our compliance credentials. Shanghai Huanghai Pharmaceutical Instruments holds FDA / GMP / ISO certifications across our pharma testing and ODF manufacturing equipment lines. View our Certifications →
Explore Complete ODF & TDDS Manufacturing Solutions
Huanghai offers end-to-end ODF film production lines — from lab-scale R&D (BY-300A / MJ150-L) to commercial manufacturing (MJ150). GMP-certified and 21 CFR Part 11 compliant.